Top-News
USA

Opko Health News

Aktie
WKN:  A0MUUJ ISIN:  US68375N1037 US-Symbol:  OPK
1,403 €
+0,0286 €
+2,08%
22.07.24
Handeln Depot/Watchlist
Aktienanzahl *
773,06 Mio.
Marktkapitalisierung *
1,06 Mrd. €
Streubesitz
23,98%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 25.11.2023

Opko Health News

02.07.24 - PR Newswire
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner
NextPlat Expands E-​Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire
28.03.24 - PR Newswire
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business PR Newswire
28.02.24 - PR Newswire
NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
NextPlat Opens OPKO Health-​Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st PR Newswire
23.02.24 - PR Newswire
Thinking about buying stock in Intuitive Machines, OPKO Health, Ardelyx, AXT Inc, or Clearmind Medicine?
Thinking about buying stock in Intuitive Machines, OPKO Health, Ardelyx, AXT Inc, or Clearmind Medicine? PR Newswire
05.02.24 - PR Newswire
NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China
NextPlat Receives Initial Approvals to Launch OPKO Health-​Branded Storefront on Alibaba's Tmall Global Platform in China PR Newswire
28.11.23 - PR Newswire
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing PR Newswire
07.11.23 - PR Newswire
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
BioReference® Signs On as the First Laboratory to Use MSK-​ACCESS® Powered with SOPHiA DDM™ PR Newswire
07.11.23 - PR Newswire
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
BioReference® Signs On as the First Laboratory to Use MSK-​ACCESS® Powered with SOPHiA DDM™ PR Newswire
29.09.23 - PR Newswire
Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma?
Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma? PR Newswire
14.07.23 - PR Newswire
Thinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences?
Thinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences? PR Newswire
06.07.23 - PR Newswire
Thinking about buying stock in Lucid Group, OPKO Health, Eos Energy Enterprises, Kartoon Studios, or Allarity Therapeutics?
Thinking about buying stock in Lucid Group, OPKO Health, Eos Energy Enterprises, Kartoon Studios, or Allarity Therapeutics? PR Newswire
28.06.23 - PR Newswire
Thinking about buying stock in Marinus Pharmaceuticals, OPKO Health, Xponential Fitness, Plug Power, or Asetek A/S?
Thinking about buying stock in Marinus Pharmaceuticals, OPKO Health, Xponential Fitness, Plug Power, or Asetek A/S? PR Newswire
09.02.23 - PR Newswire
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
BioReference Now Offers the Only FDA-​Approved Dual-​Stain Triage Test to Enhance Cervical Cancer Screenings PR Newswire
16.03.22 - PR Newswire
GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions
GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions PR Newswire
01.03.22 - PR Newswire
Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease
Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease Program Supports Access to A Pivotal Phase 3 Trial of Dichloroacetate in ...
18.01.22 - PR Newswire
Thinking about buying stock in Polarityte, Opko Health, Ion Geophysical, National CineMedia, or Playtika?
Thinking about buying stock in Polarityte, Opko Health, Ion Geophysical, National CineMedia, or Playtika? PR Newswire
18.01.22 - LYNX Analysen
Opko Health: Dieser mögliche Geheimtipp könnte sich verdoppeln
Zusammen mit dem Pharmariesen Pfizer entwickelt das Medizin- und Pharmaunternehmen ein rekombinantes menschliches Wachstumshormon, welches zur Behandlung von ...
23.12.21 - PR Newswire
Thinking about buying stock in Allakos, 22nd Century Group, Osmotica Pharmaceuticals, Banco Santander SA, or Opko Health?
Thinking about buying stock in Allakos, 22nd Century Group, Osmotica Pharmaceuticals, Banco Santander SA, or Opko Health? PR Newswire
21.09.21 - PR Newswire
GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes
GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes Largest clinical dataset of its kind driving diagnosis and discovery worldwide PR Newswire
16.08.21 - PR Newswire
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business PR Newswire

Newssuche

Videos

newspaper
18.07.24 -6,39%
Technical Trading: Gold ausgebrochen - Long Chance
Gold Long Typ: Turbo Open End WKN: JB3ZLF Hebel: 5,5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »